Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of EUR 126.83 billion. The enterprise value is 144.09 billion.

Market Cap	126.83B
Enterprise Value	144.09B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	May 13, 2024

Share Statistics

Sanofi has 1.25 billion shares outstanding. The number of shares has decreased by -5.25% in one year.

Shares Outstanding	1.25B
Shares Change (YoY)	-5.25%
Shares Change (QoQ)	-0.50%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	55.06%
Float	1.10B

Valuation Ratios

The trailing PE ratio is 30.11 and the forward PE ratio is 12.37. Sanofi's PEG ratio is 1.64.

PE Ratio	30.11
Forward PE	12.37
PS Ratio	2.69
PB Ratio	1.74
P/FCF Ratio	20.35
PEG Ratio	1.64

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.04, with an EV/FCF ratio of 23.13.

EV / Earnings	34.18
EV / Sales	3.06
EV / EBITDA	12.04
EV / EBIT	17.12
EV / FCF	23.13

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 32.54.

Current Ratio	1.00
Quick Ratio	0.52
Debt / Equity	32.54
Debt / EBITDA	1.97
Debt / FCF	3.81
Interest Coverage	14.02

Financial Efficiency

Return on equity (ROE) is 5.81% and return on invested capital (ROIC) is 5.57%.

Return on Equity (ROE)	5.81%
Return on Assets (ROA)	4.16%
Return on Capital (ROIC)	5.57%
Revenue Per Employee	546,882
Profits Per Employee	48,973
Employee Count	86,088
Asset Turnover	0.37
Inventory Turnover	1.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.02% in the last 52 weeks. The beta is 0.42, so Sanofi's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+2.02%
50-Day Moving Average	94.94
200-Day Moving Average	90.61
Relative Strength Index (RSI)	72.11
Average Volume (20 Days)	1,233,230

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of EUR 47.08 billion and earned 4.22 billion in profits. Earnings per share was 3.36.

Revenue	47.08B
Gross Profit	32.38B
Operating Income	8.50B
Pretax Income	5.58B
Net Income	4.22B
EBITDA	11.75B
EBIT	8.50B
Earnings Per Share (EPS)	3.36

Full Income Statement

Balance Sheet

The company has 6.80 billion in cash and 23.75 billion in debt, giving a net cash position of -16.96 billion or -13.53 per share.

Cash & Cash Equivalents	6.80B
Total Debt	23.75B
Net Cash	-16.96B
Net Cash Per Share	-13.53
Equity (Book Value)	73.00B
Book Value Per Share	58.10
Working Capital	54.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.12 billion and capital expenditures -1.89 billion, giving a free cash flow of 6.23 billion.

Operating Cash Flow	8.12B
Capital Expenditures	-1.89B
Free Cash Flow	6.23B
FCF Per Share	4.97

Full Cash Flow Statement

Margins

Gross margin is 68.77%, with operating and profit margins of 18.04% and 8.95%.

Gross Margin	68.77%
Operating Margin	18.04%
Pretax Margin	11.85%
Profit Margin	8.95%
EBITDA Margin	24.97%
EBIT Margin	18.04%
FCF Margin	13.23%

Dividends & Yields

This stock pays an annual dividend of 3.76, which amounts to a dividend yield of 3.72%.

Dividend Per Share	3.76
Dividend Yield	3.72%
Dividend Growth (YoY)	5.62%
Years of Dividend Growth	n/a
Payout Ratio	111.57%
Buyback Yield	5.25%
Shareholder Yield	8.96%
Earnings Yield	3.32%
FCF Yield	4.91%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a